SPAG5 upregulation in several cancers has been associated with poor prognosis (Yuan et al., 2014; Abdel-Fatah et al., 2016; Bertucci et al., 2016; Zhou et al., 2018; Li et al., 2019). The gene discussed is SPAG5; the disease is cancer.